You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
2 July 2021
Switzerland’s Galenica is boosting the Verfora consumer healthcare business in its home market by acquiring phytotherapy and complementary medicines specialist Spagyros for an undisclosed sum.
3 June 2021
Switzerland’s Galenica has boosted its Verfora consumer healthcare business by acquiring a portfolio of brands – including Vitamin D3 Wild Oil and VI-DE 3 – from Swiss company Dr. Wild & Co for an undisclosed sum.
21 January 2021
New distribution agreements and acquisitions helped lift sales at Galenica’s Products & Brands business, which mainly consists of the Verfora consumer healthcare unit, by 9.4% to CHF112 million (USD126 million) in 2020.
1 December 2020
Galenica, which owns the Verfora consumer healthcare business, is reorganising from 1 January 2021 in a move that should allow it to “develop new products and services more efficiently with shorter time-to-market”.
6 July 2020
Galenica has boosted its Verfora consumer healthcare business by acquiring Swiss company Hedoga Group – including its Osa, Osanit and Carmol brands – for an undisclosed sum.
9 April 2020
Galenica has issued financial guidance in light of the COVID-19 pandemic, Adamed has launched Maxon Forte (sildenafil) in Poland, and Sanofi Consumer Healthcare is partnering with Plug and Play Japan.
23 January 2020
Galenica’s Products & Brands business, which mainly consists of the Verfora consumer healthcare unit, has announced a number of partnerships for 2020. The news came as the business reported sales up by 11.3% in 2019.